CVS Health (CVS) Tops Q3 EPS by 9c, Beats on Revenue; Offers FY22 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $93.47 -1.07%
Revenue Growth %: +1.8%
Financial Fact:
Income from continuing operations: 1.54B
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: +1.8%
Financial Fact:
Income from continuing operations: 1.54B
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q3 EPS of $2.09, $0.09 better than the analyst estimate of $2.00. Revenue for the quarter came in at $81.16 billion versus the consensus estimate of $76.76 billion.
GUIDANCE:
CVS Health sees FY2022 EPS of $8.55-$8.65, versus the consensus of $8.55.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Top restaurant stocks to watch, according to Raymond James
- SLM (SLM) Misses Q3 EPS by 36c; lowers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
